Approved on the 7th after a Phase 3 trial showing 9.75% average weight loss. Observers expect the lowest dose could cost around 100,000 won a month.
Recap by typeshit. Full story at DongA Science.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The NAVC chief veterinary officer says research on peptides for dogs and cats is still very basic, and suggests checking with a vet first. Keeping pets lean has stronger evidence.
RTÉ reports Lilly's new pricing offer would cost Ireland about €2 to €3 billion a year if offered publicly. A Wegovy cost assessment is due soon.
Loading…